Heart failure in older people: causes, diagnosis and treatment

被引:33
作者
Abdelhafiz, AH [1 ]
机构
[1] No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England
关键词
congestive heart failure; diastolic cardiac dysfunction; systolic cardiac dysfunction;
D O I
10.1093/ageing/31.1.29
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Congestive heart failure affects >5% of those aged 65-75 and 10-20% of those aged > 80 in the UK, and levels are likely to rise in the wake of improved therapies for hypertension and myocardial infarction. It is often multi factorial in this group. The most common causes are hypertension and coronary heart disease, with valvular heart disease playing an increasing role. The most common precipitant of pre-existing heart failure is non-compliance with medication or diet; non-steroidal anti-inflammatory drugs arc particularly likely to exacerbate the condition. Diagnosis may be difficult since typical signs arc often absent or masked in older people, but plasma levels of brain natriuretic peptide appear to be a reliable indicator and may provide diagnostic test in the future. Systolic heart failure is managed by conventional therapy (diuretics, angiotensin-converting enzyme inhibitors and beta-blockers). The management of diastolic heart failure is less well defined, but symptoms should be managed, ischaemia prevented and the underlying causes identified and treated. Nurse-directed, multidisciplinary intervention (including education of patient and family, social support, review of medication, dietary modification and weight monitoring) have resulted in improvements in event-free survival and quality of life.
引用
收藏
页码:29 / 36
页数:8
相关论文
共 76 条
[1]  
ABRAHAM WT, 1998, CARDIOVASC REV REP, V19, P59
[2]   PROGNOSIS OF CONGESTIVE-HEART-FAILURE IN ELDERLY PATIENTS WITH NORMAL VERSUS ABNORMAL LEFT-VENTRICULAR SYSTOLIC FUNCTION ASSOCIATED WITH CORONARY-ARTERY DISEASE [J].
ARONOW, WS ;
AHN, C ;
KRONZON, I .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (17) :1257-1259
[3]   Additive effects of losartan and enalapril on blood pressure and plasma active renin [J].
Azizi, M ;
Guyene, TT ;
Chatellier, G ;
Wargon, M ;
Menard, J .
HYPERTENSION, 1997, 29 (02) :634-640
[4]   Pharmacological demonstration of the additive effects of angiotensin-converting enzyme inhibition and angiotensin II antagonism in sodium depleted healthy subjects [J].
Azizi, M ;
Guyene, TT ;
Chatellier, G ;
Menard, J .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 1997, 19 (5-6) :937-951
[5]   Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension [J].
Bogden, PE ;
Abbott, RD ;
Williamson, P ;
Onopa, JK ;
Koontz, LM .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1998, 13 (11) :740-745
[6]   THE NATURAL-HISTORY OF ISOLATED LEFT-VENTRICULAR DIASTOLIC DYSFUNCTION [J].
BROGAN, WC ;
HILLIS, LD ;
FLORES, ED ;
LANGE, RA .
AMERICAN JOURNAL OF MEDICINE, 1992, 92 (06) :627-630
[7]  
CARSON JL, 1994, PRINCIPLES GERIATRIC, P947
[8]   Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study [J].
Caruana, L ;
Petrie, MC ;
Davie, AP ;
McMurray, JJV .
BRITISH MEDICAL JOURNAL, 2000, 321 (7255) :215-218
[9]  
CLELAND JG, 1995, EUR HEART J, V16, P741
[10]   Perindopril for elderly people with chronic heart failure: the PEP-CHF study [J].
Cleland, JGF ;
Tendera, M ;
Adamus, J ;
Freemantle, N ;
Gray, CS ;
Lye, M ;
O'Mahony, D ;
Polonski, L ;
Taylor, J .
EUROPEAN JOURNAL OF HEART FAILURE, 1999, 1 (03) :211-217